Myopia management Archives - Insight

Atropine for myopia control: science and practice

Staff Writer — Mon, 04 Apr 2022 21:37:48 +0000

The optimum atropine concentration for myopia has been the focus of studies that have offered several twists.

At the completion of this CPD activity, optometrists will have developed their knowledge of atropine as a treatment for myopia management. Including:
Understand the clinical rationale
Read More

The post Atropine for myopia control: science and practice appeared first on Insight.

Hoya Vision Care and International Myopia Institute announce partnership

Staff Writer — Tue, 22 Mar 2022 04:24:00 +0000

A new partnership with the International Myopia Institute aligns with Hoya Vision Care’s core mission.

Hoya Vision Care and the International Myopia Institute have announced a partnership to promote advocacy and educational efforts to address and manage myopia. Their shared goal is to raise awareness about
Read More

The post Hoya Vision Care and International Myopia Institute announce partnership appeared first on Insight.

Low-dose atropine EIKANCE secures first myopia TGA approval

Staff Writer — Thu, 17 Mar 2022 23:40:17 +0000

Eikance 0.01% atropine was approved by the TGA in September 2021.

The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children and young teenagers. The eye drop therapy – with
Read More

The post Low-dose atropine EIKANCE secures first myopia TGA approval appeared first on Insight.

Myopia lens fitting requirements by Grant Hannaford – Part 2

Staff Writer — Mon, 13 Dec 2021 05:05:33 +0000

Appropriate frame selection will drive the success of the lens designs.

In the second part of his series on the dispenser’s role in myopia management, GRANT HANNAFORD covers the unique fitting demands of new and available spectacle lens options. Lens
Read More

The post Myopia lens fitting requirements by Grant Hannaford – Part 2 appeared first on Insight.

Myopia management for dispensers by Grant Hannaford – Part 1

Staff Writer — Fri, 12 Nov 2021 05:27:30 +0000

The initiative will focus on supporting eyecare professionals in building their clinical capacity to manage myopia.

Myopia’s prevalence has driven the development of innovative interventions, including spectacle lens options. GRANT HANNAFORD explains how dispensers can fit into the myopia management
Read More

The post Myopia management for dispensers by Grant Hannaford – Part 1 appeared first on Insight.

New myopia alliance to overcome axial length challenge

rhiannon bowman — Mon, 15 Feb 2021 03:42:15 +0000

Myopia Profile directors Kate and Paul Gifford (from left) and Oculus CEOs Christian and Rainer Kirchhübel. Image: Myopia Profile

Unprecedented clinical interest in measuring axial length has fuelled a new partnership between the world’s largest multi-platform digital suite for myopia management and an optical device company headquartered
Read More

The post New myopia alliance to overcome axial length challenge appeared first on Insight.

Contact lens among top 100 scientific breakthroughs of 2020

Myles Hume — Mon, 07 Dec 2020 03:08:41 +0000

MiSight is the only FDA approved treatment that can help reduce the severity of myopia progression.

CooperVision’s MiSight 1 day contact lens has been ranked in Popular Science’s top 100 innovations of 2020, alongside a fast, ultra-cheap coronavirus test, and joining past winners such as
Read More

The post Contact lens among top 100 scientific breakthroughs of 2020 appeared first on Insight.

Myopia Profile and CORE join forces

Myles Hume — Tue, 01 Dec 2020 20:20:22 +0000

Dr Kate and Dr Paul Gifford are the directors of Myopia Profile.

The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed a new alliance with the renowned Centre for Ocular Research &
Read More

The post Myopia Profile and CORE join forces appeared first on Insight.

Defusing the myopia time bomb: What will the future hold?

Myles Hume — Tue, 21 Apr 2020 05:22:55 +0000

Dr Philip Cheng says close monitoring and tailoring the treatment plan is key to optimal control of myopia progression.

Clinical optometrist DR PHILIP CHENG, who operates The Myopia Clinic Melbourne within his practice Eyecare Concepts, explains the current treatment landscape and why he believes clinical use of
Read More

The post Defusing the myopia time bomb: What will the future hold? appeared first on Insight.